Werewolf Therapeutics HOWL
NASDAQ HOWL
$1.03 -0.02 (-1.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Net Margin (2022 - 2026)

Updated

Werewolf Therapeutics (HOWL) recorded Net Margin of 17.48% in Q2 2026.

Analysis

Werewolf Therapeutics (HOWL) Net Margin (2022 - 2026) Analysis & Trends

On a TTM basis, Werewolf Therapeutics' Net Margin came in at -164.82% as of Jun 30, 2026, up 487461.84 percentage points year-over-year; for FY2024, it was -3711.32%, down 3523.94 percentage points from FY2023.

  • Across earlier years, Net Margin came in at -187.37% in FY2023 (+140.72 pp) and -328.09% in FY2022.
  • The Q2 2026 figure is the highest quarterly Net Margin in data going back to Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Werewolf Therapeutics 49.57 Mn -141.69 Mn - 17.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.48%
Dec 31, 2024 -136,000.00%
Jun 30, 2024 -1,509.10%
Mar 31, 2024 -2,182.35%
Dec 31, 2023 -799.67%
Sep 30, 2023 -140.50%
Jun 30, 2023 -63.09%
Mar 31, 2023 -268.41%
Dec 31, 2022 -163.81%
Sep 30, 2022 -240.30%
Jun 30, 2022 -351.83%
API Access

Werewolf Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=HOWL&period=max&api_key=YOUR_API_KEY